tirzepatide not on shortage list Eli Lilly's is off the FDA's drug list: Here's what it means tirzepatide off the shortage list

#T1D #Type1Diabetes #DiabetesTech #PregnancyAndDiabetes #HealthInnovation #FDAApproval #MaternalHealth #DiabetesManagement This is a significant and long-overdue step forward in Type 1 diabetes care

Here are the steps: Take The Quiz Begin by taking a quick online quiz to assess your eligibility for GLP-1 medications

Your doctor will probably start you on a low dose and gradually increase your dose, not more than once every 4 weeks

The most important thing is to be consistent and administer your dose on the same day each week

The American Diabetes Association recommends GLP-1 receptor agonists with proven cardiovascular benefit for patients with established cardiovascular disease, while SGLT2 inhibitors are preferred for chronic kidney disease protection